Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


GREY:BIOAF - Post by User

Comment by narmacon Jan 17, 2023 8:45pm
130 Views
Post# 35229560

RE:Sadly, I Think It's Checkmate

RE:Sadly, I Think It's Checkmatewell,,,,,,,its either one JD,,it cant be both,,,,,failed science or failed management..have your pick,,,it is very difficult to believe shareholders would be led to slaughter by a moral management team...!

It is also confusing to believe the future of Bioasis rests in the hands of a few 3rd parties acceptance or rejection. All separated from those who own the company's capital assets.

Along with this is our partners complacnecy who have taken a license out for our science. They must have failed to advance anything beyond being little more than having a placebo level of efficacy.

Nothing matches the years of managament promoting this technology to where we stand today. Nothing!
<< Previous
Bullboard Posts
Next >>